Inmode Share Price Today
(NASDAQ: INMD)

Name: Inmode Share Price Today (NASDAQ: INMD) - Inmode Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Inmode share price is $19.26 & ₹1,675.02 as on 6 Mar 2025, 2.30 'hrs' IST

$19.26

▲

0.44

(2.34%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Inmode share price in Dollar and Rupees. Guide to invest in Inmode stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Inmode, along with analyst recommendations, forecasts, and comprehensive financials.

Inmode share price movements

Today's Low: $18.82
Today's High: $19.30
$19.26
2.31%
Downside
Day's Volatility :2.51%
Upside
0.21%
52 Weeks Low: $14.87
52 Weeks High: $23.38
$19.26
22.79%
Downside
52 Weeks Volatility :36.4%
Upside
17.62%

Inmode (INMD) Returns

Period	Inmode Ltd	Sector (Health Care)	Index (Russel 2000)
3 Months	6.35%	3.7%	0.0%
6 Months	23.07%	-2.8%	0.0%
1 Year	-15.38%	2.5%	0.0%
3 Years	-45.47%	12.9%	-11.6%

Inmode (INMD) Key Statistics

in dollars & INR

Previous Close	$18.82
Open	$18.86
Today's High	$19.3
Today's Low	$18.815
Market Capitalization	$1.3B
Today's Volume	$879.8K
52 Week High	$23.3799
52 Week Low	$14.87
Revenue TTM	$394.8M
EBITDA	$113.3M
Earnings Per Share (EPS)	$2.24
PE Ratio	8.4
Profit Margin	45.91%
Quarterly Earnings Growth YOY	0.76%
Return On Equity TTM	24.31%

How to invest in Inmode Stock (INMD) from India?

It is very easy for Indian residents to invest directly in Inmode from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inmode stock in both Indian Rupees (INR) and US Dollars (USD). Search for Inmode or INMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inmode or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Inmode shares which would translate to 0.045 fractional shares of Inmode as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Inmode, in just a few clicks!

Returns in Inmode (INMD) for Indian investors in Rupees

The Inmode stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Inmode investment value today

Current value as on today

₹89,571

Returns

₹10,429

(-10.43%)

Returns from Inmode Stock

₹15,378 (-15.38%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Inmode (INMD)

32%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Inmode Stock from India on INDmoney has increased by 32% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Inmode

BlackRock Inc
8.62%
Renaissance Technologies Corp
3.26%
Doma Perpetual Capital Management LLC
3.22%
State Street Corp
2.88%
UBS Group AG
2.69%
LSV Asset Management
2.47%

Analyst Recommendation on Inmode

Buy

66%Buy

33%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Inmode(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Inmode Stock (INMD)

What analysts predicted

Upside of 10.76%

Target:

$21.33

Current:

$19.26

Insights on Inmode Stock (Ticker Symbol: INMD)

Price Movement
In the last 7 days, INMD stock has moved up by 3.7%
Decreasing Revenue
Revenue is down for the last 2 quarters, 130.23M → 97.85M (in $), with an average decrease of 24.9% per quarter
Increasing Net Profit
Netprofit is up for the last 5 quarters, 23.69M → 82.77M (in $), with an average increase of 23.1% per quarter
INMD vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 70.7%
INMD vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 188.1%
Price to Sales
ForINMD every $1 of sales, investors are willing to pay $3.9, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

INMD Inmode Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$156.4M	↑ 56.11%
Net Income	$61.1M	↑ 173.32%
Net Profit Margin	39.11%	↑ 16.78%

	FY20	Y/Y Change
Revenue	$206.1M	↑ 31.81%
Net Income	$75.0M	↑ 22.71%
Net Profit Margin	36.4%	↓ 2.71%

	FY21	Y/Y Change
Revenue	$357.6M	↑ 73.49%
Net Income	$165.0M	↑ 119.87%
Net Profit Margin	46.14%	↑ 9.74%

	FY22	Y/Y Change
Revenue	$454.3M	↑ 27.05%
Net Income	$161.5M	↓ 2.09%
Net Profit Margin	35.56%	↓ 10.58%

	FY23	Y/Y Change
Revenue	$492.0M	↑ 8.32%
Net Income	$197.9M	↑ 22.54%
Net Profit Margin	40.22%	↑ 4.66%

	FY24	Y/Y Change
Revenue	$394.8M	↓ 19.76%
Net Income	$181.3M	↓ 8.41%
Net Profit Margin	45.91%	↑ 5.69%

	Q3 FY23	Q/Q Change
Revenue	$126.8M	↓ 6.83%
Net Income	$55.2M	↓ 1.01%
Net Profit Margin	43.51%	↑ 2.56%

	Q4 FY23	Q/Q Change
Revenue	$80.3M	↓ 36.68%
Net Income	$23.7M	↓ 57.05%
Net Profit Margin	29.52%	↓ 13.99%

	Q1 FY24	Q/Q Change
Revenue	$86.4M	↑ 7.68%
Net Income	$23.8M	↑ 0.51%
Net Profit Margin	27.55%	↓ 1.97%

	Q2 FY24	Q/Q Change
Revenue	$86.4M	↑ 0.0%
Net Income	$23.8M	↑ 0.0%
Net Profit Margin	27.55%	↑ 0.0%

	Q3 FY24	Q/Q Change
Revenue	$130.2M	↑ 50.65%
Net Income	$51.0M	↑ 114.08%
Net Profit Margin	39.15%	↑ 11.6%

	Q4 FY24	Q/Q Change
Revenue	$97.9M	↓ 24.86%
Net Income	$82.8M	↑ 62.33%
Net Profit Margin	84.59%	↑ 45.44%

	FY19	Y/Y Change
Profit	$136.1M	↑ 59.95%

	FY20	Y/Y Change
Profit	$175.3M	↑ 28.75%

	FY21	Y/Y Change
Profit	$304.0M	↑ 73.44%

	FY22	Y/Y Change
Profit	$380.8M	↑ 25.27%

	FY23	Y/Y Change
Profit	$411.3M	↑ 8.02%

	FY24	Y/Y Change
Profit	$317.1M	↓ 22.92%

	Q3 FY23	Q/Q Change
Profit	$106.5M	↓ 6.59%

	Q4 FY23	Q/Q Change
Profit	$63.9M	↓ 39.99%

	Q1 FY24	Q/Q Change
Profit	$69.3M	↑ 8.47%

	Q2 FY24	Q/Q Change
Profit	$69.3M	↑ 0.0%

	Q3 FY24	Q/Q Change
Profit	$106.2M	↑ 53.14%

	Q4 FY24	Q/Q Change
Profit	$77.6M	↓ 26.88%

	FY19	Y/Y Change
Operating Cash Flow	$62.2M	↑ 68.64%
Investing Cash Flow	$-112.5M	↑ 278.13%
Financing Cash Flow	$70.2M	↑ 37627.42%

	FY20	Y/Y Change
Operating Cash Flow	$79.2M	↑ 27.36%
Investing Cash Flow	$-43.3M	↓ 61.49%
Financing Cash Flow	$-12.4M	↓ 117.73%

	FY21	Y/Y Change
Operating Cash Flow	$174.9M	↑ 120.74%
Investing Cash Flow	$-160.1M	↑ 269.72%
Financing Cash Flow	$-15.0M	↑ 20.74%

	FY22	Y/Y Change
Operating Cash Flow	$181.6M	↑ 3.83%
Investing Cash Flow	$-109.5M	↓ 31.62%
Financing Cash Flow	$-41.1M	↑ 173.5%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$61.3M	↑ 15.6%
Investing Cash Flow	$-69.8M	↑ 0.0%
Financing Cash Flow	$275.0K	↓ 66.75%

Inmode Technicals Summary

Sell

Neutral

Buy

Inmode is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Inmode (INMD) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inmode Ltd	10.06%	23.07%	-15.38%	-45.47%	39.67%
Medtronic Plc	3.4%	5.22%	9.95%	-11.8%	1.8%
Edwards Lifesciences Corp.	2.13%	10.35%	-17.53%	-32.76%	14.39%
Boston Scientific Corp.	1.13%	28.68%	55.31%	146.09%	207.16%
Stryker Corporation	0.84%	10.53%	11.46%	56.15%	129.21%
Abbott Laboratories	6.67%	21.76%	15.39%	15.86%	78.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inmode Ltd	8.4	8.4	2.9	1.94	0.24	0.09	NA	10.12
Medtronic Plc	28.71	28.71	1.91	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	31.13	31.13	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	84.24	84.24	1.87	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.77	50.77	2.91	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inmode Ltd	Buy	$1.3B	39.67%	8.4	45.91%
Medtronic Plc	Buy	$119.3B	1.8%	28.71	12.83%
Edwards Lifesciences Corp.	Buy	$42.8B	14.39%	31.13	76.75%
Boston Scientific Corp.	Buy	$152.9B	207.16%	84.24	11.07%
Stryker Corporation	Buy	$148.8B	129.21%	50.77	13.25%
Abbott Laboratories	Buy	$238.6B	78.8%	18.34	31.95%

About Inmode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Organization	Inmode
Employees	599
CEO	Mr. Moshe Mizrahy
Industry	Health Technology

Management People of Inmode

Name	Title
Mr. Yair Malca	Chief Financial Officer
Mr. Matt Rodgers	Vice President of Sales of Canada
Mr. Brandon Nye	Vice President of Sales of West US
Mr. Michael Dennison	Vice President of Sales - East US
Mr. Moshe Mizrahy	Co-Founder, CEO & Director
Dr. Michael Kreindel	Co-Founder, CTO & Director
Ms. Nava Tal-Launer	Chief Information Officer

Important FAQs about investing in INMD Stock from India :

What is Inmode share price today?

Inmode share price today stands at $19.26, Open: $18.86 ; Previous Close: $18.82 ; High: $19.30 ; Low: $18.82 ; 52 Week High: $23.38 ; 52 Week Low: $14.87.

The stock opens at $18.86, after a previous close of $18.82. The stock reached a daily high of $19.30 and a low of $18.82, with a 52-week high of $23.38 and a 52-week low of $14.87.

Can Indians buy Inmode shares?

Yes, Indians can invest in the Inmode (INMD) from India.

With INDmoney, you can buy Inmode at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Inmode at zero transaction cost.

How can I buy Inmode shares from India?

It is very easy to buy Inmode from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Inmode (INMD) be purchased?

Yes, you can buy fractional shares of Inmode with INDmoney app.

What are the documents required to start investing in Inmode stocks?

To start investing in Inmode, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.